bodyType

customContents

entityId

entityUuid

articlePageQuery

filter

article

articleBaseAdvertisingInfoArticle

articleListArticle

articleSeoArticle

helpersCheckIsPostiesArticle

hooksArticleAcknowledgementGateOverlayArticle

hooksTrackPageViewArticle

hooksContentInterestArticle

articleLinkingDataContent

articleSchemaContent

liveArticle

advertZone

sentiment

contentLock

topics

types

sections

moreOnThisArticles

urlAlias

commentCount

sponsorType

authorLocations

authors

paywallTypes

corrections

displaySlideShow

multimediaEmbed

printHeadline

seriesContainer

socialHeadline

headline

flag

firstTopic

glossary

flattenTypeIds

publishedDate

additionalInfoBoxes

images

image

relatedLinks

relatedNewsletters

__typename

createdDate

sponsor

factSheets

series

disableOffPlatformContent

published

updatedDate

summary

subHeadline

body

keywords

copyrighted

customTimezone

liveContents

Associated Press

The verdict in Maria Sharapova’s appeal against a two-year doping ban will be announced on Tuesday.
The Court of Arbitration for Sport says it will issue the decision at 3pm local time.
Sharapova challenged an International Tennis Federation (ITF) ban imposed after she tested positive at the Australian Open for meldonium.

An ITF panel found that the Russian did not intend to cheat, but was at “very significant fault”.
Sharapova acknowledged taking meldonium before each match in Melbourne, claiming she was not aware it had been banned by the World Anti-Doping Agency.
Sharapova said she was prescribed the Latvian-made heart drug since 2006. Meldonium, also known as mildronate, is not approved for use in the United States where she lives.
Her ban expires in January 2018.


Maria Sharapova to learn of verdict on doping appeal by Tuesday

(FILES) This file photo taken on March 07, 2016 shows Russian tennis player Maria Sharapova speaking during a press conference in Los Angeles. Russian tennis star Maria Sharapova has been banned for two years after failing a drug test, the International Tennis Federation (ITF) announced on June 8, 2016. Sharapova tested positive for the controversial banned medication meldonium during January's Australian Open. / AFP PHOTO / ROBYN BECK

Maria Sharapova of Russia speaks during a news conference at the Brisbane International tennis tournament in Brisbane, Australia on January 1, 2013. REUTERS/Daniel Munoz/File Photo TPX IMAGES OF THE DAY

Buried message: Maria Sharapova lashes out at critics over positive test

Maria Sharapova said warnings about the impending ban on meldonium were buried in official literature. Photo: AFP

Maria Sharapova of Russia holds the trophy after winning the French Open tennis tournament in Paris in this June 7, 2014 file photo. REUTERS/Vincent Kessler/Files

Maria Sharapova of Russia wipes her face during her women's singles match against Lucie Safarova of the Czech Republic during the French Open tennis tournament at the Roland Garros stadium in Paris, France, in this June 1, 2015 file picture. Russian tennis star Maria Sharapova, the highest-paid woman in sports, said on March 7, 2016 that she failed a drug test at the Australian Open due to a substance she has been taking for 10 years for health issues. Hours after the announcement, one of her biggest sponsors, Nike Inc., said it had suspended its relationship with her while the investigation continues, cable news channel CNBC reported. REUTERS/Gonzalo Fuentes/Files

Sport

Tennis

Russian tennis star has challenged an ITF-imposed two-year doping ban for taking meldonium
